The role of Syk kinase in ultraviolet-mediated skin damage

British Journal of Dermatology

Volumn 165, Issue 1, 2011, Pages 69-77

  Papazoglou, E ^a   Huang, Z Y ^a   Sunkari, C ^a   Uitto, J ^b  

^a DREXEL UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; COLLAGENASE 3; COMPLEMENTARY DNA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PICEATANNOL; PROTEIN KINASE SYK; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HAIRLESS MOUSE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN FIBROBLAST; TRANSIENT TRANSFECTION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FIBROBLASTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MICE; MICE, HAIRLESS; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; ULTRAVIOLET RAYS;

EID: 79959749329     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10309.x     Document Type: Article

References (45)

1. Taniguchi T, Kobayashi T, Kondo J, et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem 1991; 266: 15790-6. (Pubitemid 21907727)
2. Yanagi S, Kurosaki T, Yamamura H,. The structure and function of nonreceptor tyrosine kinase p72syk expressed in hematopoietic cells. Cell Signal 1995; 7: 185-93.
3. Cheng AM, Rowley B, Pao W, et al. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995; 378: 303-6.
4. Turner M, Mee PJ, Costello PS, et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995; 378: 298-302.
5. Kiefer F, Brumell J, Al-Alawi N, et al. The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils. Mol Cell Biol 1998; 18: 4209-20. (Pubitemid 28287944)
6. Coopman PJ, Do MT, Barth M, et al. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 2000; 406: 742-7.
7. Wang H, Malbon CC,. G(s) alpha repression of adipogenesis via Syk. J Biol Chem 1999; 274: 32159-66.
8. Yamada T, Fujieda S, Yanagi S, et al. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines. J Immunol 2001; 167: 283-8. (Pubitemid 32567790)
9. Toyama T, Iwase H, Yamashita H, et al. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 2003; 189: 97-102. (Pubitemid 35351524)
10. Wang S, Ding YB, Chen GY, et al. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2004; 10: 1815-18. (Pubitemid 38931212)
11. Kienle DL, Korz C, Hosch B, et al. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J Clin Oncol 2005; 23: 3780-92.
12. Thompson MA, Stumph J, Henrickson SE, et al. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 2005; 36: 494-504. (Pubitemid 40776002)
13. Qin S, Minami Y, Hibi M, et al. Syk-dependent and -independent signaling cascades in B cells elicited by osmotic and oxidative stress. J Biol Chem 1997; 272: 2098-103. (Pubitemid 27058485)
14. Wang SF, Yen JC, Yin PH, et al. Involvement of oxidative stress-activated JNK signaling in the methamphetamine-induced cell death of human SH-SY5Y cells. Toxicology 2008; 246: 234-41.
15. Hirasawa N, Scharenberg A, Yamamura H, et al. A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor. J Biol Chem 1995; 270: 10960-7.
16. Zhang J, Berenstein EH, Evans RL, et al. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med 1996; 184: 71-9. (Pubitemid 26247216)
17. Jacinto E, Werlen G, Karin M,. Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity 1998; 8: 31-41. (Pubitemid 28097821)
18. Jiang A, Craxton A, Kurosaki T, et al. Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J Exp Med 1998; 188: 1297-306. (Pubitemid 28478018)
19. Arudchandran R, Brown MJ, Peirce MJ, et al. The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of c-Jun NH(2)-terminal kinase 1. J Exp Med 2000; 191: 47-60.
20. Manetz TS, Gonzalez-Espinosa C, Arudchandran R, et al. Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells. Mol Cell Biol 2001; 21: 3763-74. (Pubitemid 32466989)
21. Kyriakis JM, Avruch J,. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-69. (Pubitemid 32267078)
22. Yousefi S, Hoessli DC, Blaser K, et al. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996; 183: 1407-14. (Pubitemid 26134284)
23. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-31.
24. Chang L, Karin M,. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40. (Pubitemid 32225829)
25. She QB, Ma WY, Dong Z,. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20. Oncogene 2002; 21: 1580-9. (Pubitemid 34226146)
26. Wang W, Chen JX, Liao R, et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22: 3389-403. (Pubitemid 34453979)
27. Hildesheim J, Awwad RT, Fornace AJ Jr,. p38 Mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. J Invest Dermatol 2004; 122: 497-502. (Pubitemid 38281075)
28. de Gruijl FR,. Skin cancer and solar UV radiation. Eur J Cancer 1999; 35: 2003-9. (Pubitemid 30026221)
29. de Gruijl FR,. Photocarcinogenesis: UVA vs UVB. Methods Enzymol 2000; 319: 359-66. (Pubitemid 30448057)
30. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-11.
31. Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379: 335-9. (Pubitemid 26033074)
32. Kerkela E, Saarialho-Kere U,. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 2003; 12: 109-25. (Pubitemid 36934696)
33. Bruckner-Tuderman L,. Biology of the extracellular matrix. In: Dermatology (, Bolognia JL, Jorizzo JL, Rapini RP, eds), 2nd edn. London: Elsevier, 2007; 1447-54.
34. Papazoglou E, Sunkari C, Neidrauer M, et al. Noninvasive assessment of UV-induced skin damage: comparison of optical measurements to histology and MMP expression. Photochem Photobiol 2010; 86: 138-45.
35. de Gruijl FR, Forbes PD,. UV-induced skin cancer in a hairless mouse model. Bioessays 1995; 17: 651-60.
36. Speich HE, Grgurevich S, Kueter TJ, et al. Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress. Am J Physiol Cell Physiol 2008; 295: C1045-54.
37. Sulimenko V, Draberova E, Sulimenko T, et al. Regulation of microtubule formation in activated mast cells by complexes of gamma-tubulin with Fyn and Syk kinases. J Immunol 2006; 176: 7243-53. (Pubitemid 43849024)
38. Weinblatt ME, Kavanaugh A, Genovese MC, et al. An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. N Engl J Med 2010; 363: 1303-12.
39. Pamuk ON, Lapchak PH, Rani P, et al. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2010; 299: G391-9.
40. Deng G-M, Liu L, Bahjat FR, et al. Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice. Arthritis Rheum 2010; 62: 2086-92.
41. Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138: 1462-70. (Pubitemid 35315736)
42. Cha H-S, Boyle DL, Inoue T, et al. A novel spleen tyrosine kinase inhibitor blocks c-Jun N terminal kinase-mediated gene expression in synoviocytes. J Pharmacol Exp Ther 2006; 317: 571-8.
43. Gu M, Dhanalakshmi S, Mohan S, et al. Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin. Carcinogenesis 2005; 26: 1404-13. (Pubitemid 41417883)
44. Bomser JA,. Selective induction of mitogen-activated protein kinases in human lens epithelial cells by ultraviolet radiation. J Biochem Mol Toxicol 2002; 16: 33-40. (Pubitemid 34211261)
45. Nakamura S, Takahashi H, Kinouchi M, et al. Differential phosphorylation of mitogen-activated protein kinase families by epidermal growth factor and ultraviolet B irradiation in SV40-transformed human keratinocytes. J Dermatol Sci 2001; 25: 139-49. (Pubitemid 32054705)